Answers are grounded in this paper and cite their sources.
Alzheimer's disease (AD) is the most common form of dementia in the elderly and the fourth leading cause of death in Western countries. Glycogen synthase kinase 3β (GSK3β) plays a major role in the initiation and progress of AD. Hence, an inhibition of GSK3β could be a powerful strategy to slow down or even prevent the progression of AD. In this study methanolic extracts of plants from traditional Chinese medicine (TCM) were tested for an inhibition of GSK3β activity in vitro. An enzymatic radioactivity assay based on the phophorylation of phosphatase inhibitor 2 by GSK3β was used. To assess the cytotoxicity of the extracts in COS7 cells, a colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyltetrazolium bromide] assay was performed. Out of the 20 TCM plants tested, extracts of Polygonum multiflorum , Sanguisorba spp. and Scutellaria baicalensis showed an apparent inhibition of GSK3β. The extracts showed remarkably low cytoxicity. These findings suggest that traditional Chinese medical plants represent an important source of natural compounds that affect the activity of GSK3β, which might be interesting drug candidates to slow down or even prevent the progression of AD.
No takes yet. Share an insight, caveat, or question.
Kaufmann et al. (2009) studied this question.
Synapse has enriched 7 related papers. Consider them for comparative context: